BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21298775)

  • 1. Flow cytometric osmotic fragility--an effective screening approach for red cell membranopathies.
    Warang P; Gupta M; Kedar P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2011 May; 80(3):186-90. PubMed ID: 21298775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders.
    Tachavanich K; Tanphaichitr VS; Utto W; Viprakasit V
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):570-5. PubMed ID: 19842445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric detection of erythrocyte osmotic fragility.
    Won DI; Suh JS
    Cytometry B Clin Cytom; 2009 Mar; 76(2):135-41. PubMed ID: 18727072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
    Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
    Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric osmotic fragility test: Increased assay sensitivity for clinical application in pediatric hematology.
    Ciepiela O; Adamowicz-Salach A; Zgodzińska A; Łazowska M; Kotuła I
    Cytometry B Clin Cytom; 2018 Jan; 94(1):189-195. PubMed ID: 28103644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary red cell membrane disorders and laboratory diagnostic testing.
    King MJ; Zanella A
    Int J Lab Hematol; 2013 Jun; 35(3):237-43. PubMed ID: 23480868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flowcytometric diagnostics of hereditary spherocytosis].
    Riley CH; Nikolajsen K; Kjaersgaard E; Klausen TW; Mourits-Andersen T; Clausen N; Lausen B; Rosthøj S; Birgens H
    Ugeskr Laeger; 2009 Nov; 171(49):3610-4. PubMed ID: 19954702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of imaging flow cytometry in the diagnostic assessment of red cell membrane disorders.
    More TA; Dalal B; Devendra R; Warang P; Shankarkumar A; Kedar P
    Cytometry B Clin Cytom; 2020 May; 98(3):238-249. PubMed ID: 31750618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of patients with hereditary spherocytosis - an Indian scenario.
    Manivannan P; Tyagi S; Chandra D; Mishra P; Pati HP; Saxena R
    Hematology; 2018 Apr; 23(3):175-180. PubMed ID: 28914173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric osmotic fragility testing does reflect the clinical severity of hereditary spherocytosis.
    Shim YJ; Won DI
    Cytometry B Clin Cytom; 2014 Nov; 86(6):436-43. PubMed ID: 24243866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
    King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
    Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
    Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
    Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in laboratory diagnosis of hereditary spherocytosis.
    Farias MG
    Clin Chem Lab Med; 2017 Jun; 55(7):944-948. PubMed ID: 27837594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incubated osmotic fragility test does not exclude red blood cell membrane disorders! About a case of hereditary elliptocytosis].
    Perrin J; Marchand-Arvier M; Latger-Cannard V; Vigneron C; Lecompte T
    Ann Biol Clin (Paris); 2006; 64(5):491-5. PubMed ID: 17040882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of hyperdense cells: Automated parameter to hereditary spherocytosis screening.
    Farias MG; Freitas PA
    Clin Biochem; 2015 Dec; 48(18):1341-3. PubMed ID: 26210847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of Method for Detecting Red Blood Cell Osmotic Fragility by Flow Cytometry].
    Zhu HY; Meng Q; Ouyan HM; Dong T; Zhang QY; Zhou YQ; Ping ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):229-32. PubMed ID: 26913426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia.
    King MJ; Behrens J; Rogers C; Flynn C; Greenwood D; Chambers K
    Br J Haematol; 2000 Dec; 111(3):924-33. PubMed ID: 11122157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Flow-Cytometric Osmotic Fragility Test for Hereditary Spherocytosis in Chinese Patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Deng XL; Chen WQ; Lin FQ
    Acta Haematol; 2016; 135(2):88-93. PubMed ID: 26505491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.